Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1986-04-17
1988-07-05
Terapane, John F.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 128654, 128659, 604 4, A61K 4902, A61K 4900, A61B 600
Patent
active
047553758
ABSTRACT:
Disclosed herein are a method and kit for the preparation of .sup.99m Tc labeled red blood cells using whole blood in a closed sterile system containing stannous tin in a form such that it will enter the red blood cells and be available therein for the reduction of technetium.
REFERENCES:
patent: 3725295 (1973-04-01), Echelman et al.
patent: 3988429 (1976-10-01), Richards et al.
patent: 3991173 (1976-11-01), Sinn et al.
patent: 4097238 (1978-06-01), Ashley
patent: 4300569 (1981-11-01), Bonneau
patent: 4313928 (1982-02-01), Kato et al.
patent: 4342740 (1982-08-01), Narra et al.
patent: 4372294 (1983-02-01), Strauss et al.
patent: 4443426 (1984-04-01), Thakur
patent: 4692324 (1987-09-01), Davis et al.
Srivasta et al., Abstract, Society of Nuclear Medicine, 30th Annual Meeting, St. Louis, Jun., 1983.
Larson et al., Eur. J. Nuclear Medicine, 3, 227-231 (1978).
Porter et al., J. Nuclear Medicine, 24(5), 383-387 (1983).
Babich John W.
Richards Powell
Srivastava Suresh C.
Straub Rita
Associated Universities Inc.
Bogosian Margaret C.
Terapane John F.
Thomas J. E.
LandOfFree
Method and kit for the selective labeling of red blood cells in does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and kit for the selective labeling of red blood cells in , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and kit for the selective labeling of red blood cells in will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2331469